Prediction models for incident stroke in the community: a systematic review and meta-analysis of predictive performance

社区卒中发病率预测模型:预测性能的系统评价和荟萃分析

阅读:3

Abstract

AIMS: Stroke is the second leading cause of death and the third leading cause of disability worldwide. We performed a systematic review and meta-analysis of multivariable models applicable to the prediction of incident stroke in community cohorts. METHODS AND RESULTS: Ovid Medline and Embase were searched for studies related to stroke and prediction models from inception to 3 November 2025. Measures of discrimination were extracted and pooled by Bayesian meta-analysis, with heterogeneity assessed through a 95% prediction interval (PI). Risk of bias was assessed using the Prediction model Risk Of Bias Assessment Tool and certainty in effect estimates by Grading of Recommendations, Assessment, Development and Evaluation. Forty-one studies met the inclusion criteria, describing 80 prediction models, with two (R-FSRS and Basic IS) eligible for meta-analysis, including 969 514 participants. Both R-FSRS (summary c-statistic 0.714, 95% CI 0.681-0.747) and Basic IS (0.709, 95% CI 0.647-0.769) showed acceptable discrimination performance. Risk of bias was high in 66% of models, and both models showed reduced performance when excluding development cohorts and studies at high risk of bias (R-FSRS, 0.667, 95% CI 0.604-0.727; Basic IS 0.701; 95% CI 0.583-0.807). Only 43% of studies reported calibration, and no model underwent clinical utility analysis or a clinical impact study. CONCLUSION: Many models have been derived for stroke prediction, however, they are rarely externally validated, and studies are limited by a high risk of bias, poor reporting of calibration and a lack of clinical utility analysis or prospective validation. Thus, the evidence base is insufficient to translate these models to clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。